Vous êtes sur : Accueil > Actualités
RSS Feed
|

Actualités

Précédent 1 2 3 4 5 Suivant

Belgian Yves Jongen: one of the three nominees for the European Inventor lifetime achievement Award for proton therapy cancer treatment

Yves Jongen a true pioneer in the domain of proton therapy was selected as one of the three nominees for the European Inventor lifetime achievement Award for his development of proton therapy to cure

Lire +

UCB (Braine-l'Alleud, Belgium) and FivePrime Therapeutics (San Francisco, CA.) in collaboration for the discovery of innovative biologic targets and therapeutics

UCB and Five Prime Therapeutics have recently entered a strategic collaboration for the discovery of innovative biologics targets and therapeutics for fibrosis-related inflammatory diseases and

Lire +

ULB (Brussels) inaugurates Neuroscience Institute (UNI) focusing on the complexity of the brain!

The ULB is demonstrating great innovation with the newly inaugurated ULB Neuroscience Institute (UNI) by taking into account the dimensions of the brain's complexity, from molecular neuroscience to

Lire +

Cardio3 BioSciences' publishes Phase II trial results for stem cell therapy treatment in the JACC and increases its equity by €19 million.

Two exciting new announcements have recently been made by Belgian-based biotechnology company Cardio3 BioSciences(Mont-Saint Guibert, Wallonia). In early April the company announced the publication

Lire +

Human Waves (ULB, UMons) awarded prize for innovation at the Haute Ecole Condorcet (HEPH) “Talents de la Création” competition.

Human Waves has been awarded the prize for innovation at the Haute Ecole Condorcet (HEPH) “Talents de la Création” competition. On May 3rd, students of the 2nd Marketing BA of the HEPH announced the

Lire +

ZENTECH BIOTECHNOLOGY of Liège Science Park in Belgium is now incorporated in ASIA!

ZENTECH BIOTECHNOLOGY ASIA, based in Singapore, has recently been incorporated and has proudly announced that the implementation of its ASEAN strategy is well under way. Since 2006, ZenTech has

Lire +

OncoDNA of Belgium provides first partnership in Molecular Diagnostics outside of the US for CollabRx, Inc

Belgium based OncoDNA SA, a company providing DNA next generation sequencing (NGS) tests for clinical use in cancer, recently announced a multi-year agreement to purchase CollabRx‘s SaaS-based

Lire +

New developments further strengthen Bone Therapeutics' cell product manufacturing capabilities

Updating on the February 15 th post , some exciting new developments have recently occurred that further strengthen Bone Therapeutics' cell product manufacturing capabilities. Following a

Lire +

Mithra pharmaceuticals: making the most of its Belgian homeland with new Liège investment and creation of 160 jobs

François Fornieri, founder and CEO of Mithra Pharmaceuticals and former manager of the year in 2011(Trends-Tendances), recently announced he will be making an important €40-50 million long-term

Lire +

DNAlytics, a Belgian-based SME, introduces new diagnostic solution to help rheumatologists and orthopedic surgeons identify rheumatoid arthritis at the early onset

In keeping in line with their intent to develop a culture of innovation with a focus on the patient; and to be the reference partner in data analysis for predictive and personalized medicine for the

Lire +
Précédent 1 2 3 4 5 Suivant

Actualités

Belgian Yves Jongen: one of the three nominees for the European Inventor lifetime achievement Award for proton therapy cancer treatment

Yves Jongen a true pioneer in the domain of proton therapy was selected as one of the three nominees...

UCB (Braine-l'Alleud, Belgium) and FivePrime Therapeutics (San Francisco, CA.) in collaboration for the discovery of innovative biologic targets and therapeutics

UCB and Five Prime Therapeutics have recently entered a strategic collaboration for the discovery of...

ULB (Brussels) inaugurates Neuroscience Institute (UNI) focusing on the complexity of the brain!

The ULB is demonstrating great innovation with the newly inaugurated ULB Neuroscience Institute (UNI)...
Actualités

Extranet

Mot de passe perdu ?